Article Details
Retrieved on: 2018-04-19 16:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>BlackRock Inc</b>. decreased its holdings in shares of BioSpecifics Technologies Co. (NASDAQ:BSTC) by 4.0% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 371,585 shares of the biopharmaceutical company's stock after selling 15,324 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here